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Abstract
Introduction
The object of this study was to examine the effect of pop-
ulation-based disease management and case management
on resource use, self-reported health status, and member
satisfaction with and retention in a Medicare Plus Choice
health maintenance organization (HMO).
Methods
Study design consisted of a prospective, randomized con-
trolled open trial of 18 months’ duration. Participants were
8504 Medicare beneficiaries aged 65 and older who had
been continuously enrolled for at least 12 months in a net-
work model Medicare Plus Choice HMO serving a con-
tiguous nine-county metropolitan area. Members were
care managed with an expert clinical information system
and frequent telephone contact. Main outcomes included
self-reported health status measured by the Medical
Outcomes Study 36-Item Short-Form Health Survey (SF-
36), resource use measured by admission rates and bed-
days per thousand per year, member satisfaction, and
costs measured by paid claims.
Results
More favorable outcomes occurred in the intervention
group for satisfaction with the health plan (P < .01) and
the social function domain as measured by SF-36 (P = .04).
There was no difference in member retention or mortality
between groups. Use of skilled nursing home services was
significantly lower in the intervention group than in the
control (616 vs 747 days per thousand members per year,
P = .02). This reduction, however, did not lead to lower
mean total expenditures in the intervention group com-
pared with the control ($6828 per member for 18 months
vs $7001, P = .61).
Conclusion
Population-based disease management and case man-
agement led to improved self-reported satisfaction and
social function but not to a global net decrease in resource
use or improved member retention.
Introduction
Although the United States is a wealthy country, our
elders suffer from high rates of chronic disease, social iso-
lation, poor diet, lack of mobility, and suboptimal function
(1,2). 
Indeed, chronic disease has now become the greatest
challenge to the health care system, accounting for 76% of
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direct health care costs (not including nursing home care)
(3). By not adequately addressing these issues, our elderly
population ranks lower than many other industrialized
countries on a number of public health measures (4-6). 
To give Medicare recipients the option to enroll in health
maintenance organizations (HMOs), Congress created the
Medicare Plus Choice program with passage of the
Balanced Budget Act in 1998. Many HMOs attempt to
improve health outcomes and reduce medical expenditures
through disease management and case management.
Several case management demonstration projects have
failed to affect service use, cost, or health outcomes (7). As
one senior health services researcher notes, “The case for
case management still remains to be established defini-
tively” (8). Still, managing chronic disease through a com-
bination of traditional institutional-based health care and
community-based interventions, supported by clinical
information systems, remains a compelling model (8-11).
Several variations of this comprehensive approach to pre-
ventive and chronic care are being tested (12). 
A newer paradigm is that of population-based disease
management, wherein subgroups of patients that have
modifiable risk factors for adverse medical outcomes are
identified and then entered into a program designed to
improve self-care (13). Because it is not known if disease
management programs can improve health outcomes or
produce long-term savings (14), the concept of testing pop-
ulation-based disease management in fee-for-service
Medicare is under study at the Centers for Medicare &
Medicaid Services (13). 
Most reported trials have investigated the efficacy of dis-
ease management on single disease states, such as con-
gestive heart failure or chronic obstructive lung disease.
We report a randomized controlled open trial of case man-
agement and population-based disease management that
addressed multiple disease states in a parallel, concurrent,
and patient-centric fashion.
Methods 
The Senior Life Management program
The Senior Life Management (SLM) program was
designed to provide population-based disease manage-
ment (helping members with certain disease states —
such as congestive heart failure, identified through analy-
sis of plan data — to improve self-care) and case manage-
ment (helping individual members with complex problems
to obtain needed medical and social services). The program
comprised enhanced administrative services rather than
new benefits. SLM was also crafted to be patient-centric
(in which one manager would develop a relationship with
the member), rather than disease-specific (in which a
member would be directed to multiple managers for dif-
ferent problems and disease states). Central to the pro-
gram were the following components: creation of an 
electronic care-management record; comprehensive, peri-
odic member health status assessments; telephonic case
management; patient education materials; community
physician education; and coordination with community
services. 
SLM services were added to existing services of a
Medicare Plus Choice HMO. The basic benefits included a
deductible representing only 10% of the deductible for tra-
ditional Medicare for hospitalization, enhanced skilled
nursing benefits with no three-day hospitalization prereq-
uisite and no copayments for 100 days, and a limited phar-
macy benefit.
SLM also included a drug utilization review program for
thirty medications considered to be relatively contraindi-
cated for use in the elderly based upon published guide-
lines (15). The filling of one of these prescriptions triggered
a fax to the prescribing physician asking for reconsidera-
tion of this therapeutic maneuver and soliciting physician
feedback concerning the usefulness of this alert and his or
her response. 
The Master Console, an electronic health care manage-
ment record, was created to deliver just-in-time informa-
tion to the program’s administrative and case management
staff. This electronic record integrated historical medical
claims, daily updates of current medical claims data,
monthly updates of laboratory test results and prescription
information, and data from assessments of members’
health through a survey and regularly scheduled phone
calls. The Master Console was developed with a Visual
Basic client, which allowed rapid prototyping, revision
based on end-user feedback, and deployment of upgrades.
No physician-based medical records were part of Master
Console. Decision support algorithms built into the Master
Console alerted program staff to potential changes in the
clinical status of a patient, need for case management
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at the judgment of the nurse care coordinator [NCC]
based at the HMO), or the potential need for a service
intervention. For example, authorization of a joint
replacement procedure would trigger a task/reminder for
an outbound phone call by a registered nurse care coordi-
nator the following day to determine anticipated therapy
needs in addition to a prompt to perform both a home-
safety assessment and a falls-risk assessment. As anoth-
er example, the filling of a prescription for flurazepam
would trigger a fax to the prescribing physician about the
relative contraindication of long-acting benzodiazepines
in the elderly and asking for reconsideration of this ther-
apeutic maneuver. 
Prior to initiating SLM, 72% of the 8504 study partici-
pants completed either 1) a mailed health assessment (the
Medical Outcomes Study 36-Item Short-Form Health
Survey [SF-36]) (16) along with satisfaction questions from
the Medicare Beneficiary Survey or 2) follow-up telephone
surveys if they had not returned their mail-in form.
Participant responses were summarized and entered into
the Master Console. Subsequently, periodic 18-item short
assessments of program participants were performed
quarterly over the telephone by program staff, and the
data were entered into the database. 
Program staff were organized into four teams, each
managing 800 to 1000 SLM participants. A team consist-
ed of an NCC, who supervised two personal service repre-
sentatives (PSRs). The PSR was a new level of staffing
created specifically for this intervention. PSRs were not
required to have clinical training but were selected based
on communication skills and sensitivity to geriatric issues
as ascertained by interviews with experienced nurse cli-
nicians. PSRs were provided with eight weeks of intensive
training consisting of didactic sessions covering common
geriatric issues, in addition to direct critiquing and refine-
ment of telephone communication skills by allowing
trainees to handle customer service calls in tandem with
supervisors. After training, PSRs handled outbound
phone contacts and performed periodic health screenings
with scripted questionnaires. The NCC was responsible
for outbound contact to all those in complex case manage-
ment (50 to 70 participants per team), communicating
with treating physicians and office staff, following up on
hospitalizations and ER visits, and arranging for home
health care and durable equipment through the primary
care physician. 
A full-time medical director, administrator, and social
worker also staffed the SLM program. Prior to the pro-
gram’s onset, the medical director conducted visits with
more than 100 of the primary care doctors who cared for
SLM members to brief them on the intervention and to
solicit their cooperation in coordinating services. The med-
ical director and social worker provided ad hoc consulta-
tion to care management teams for any issues related to
their areas of expertise.
SLM members who scored in the lowest quintile of the
General Health scale on the SF-36 were further assessed
by phone for possible case management by NCCs. At least
every three months, PSRs contacted all members in the
intervention group not currently in case management to
perform an 18-question short assessment. This question-
naire was designed to probe for significant changes in
physical health, mental health, or social supports.
Questions dealt with such domains as stresses and losses,
falls, pain, changes in activities of daily living, inconti-
nence, nutrition, and mood. Logic built into the short
assessment triggered further evaluation by other clini-
cians. For example, report of a fall would trigger a home
safety assessment, whereas loss of a loved one or pet would
trigger a depression evaluation by the social worker. PSRs
also fulfilled a customer service role, fielding inbound calls
from members. This provided an opportunity to probe fur-
ther for changes in health status.
Disease management modules were developed for con-
gestive heart failure, falls (home safety), nutrition,
depression, and diabetes mellitus. These conditions were
chosen because they were prevalent, contributed to mor-
bidity, and were deemed actionable. Based upon decision
support algorithms, targeted educational materials
(selected by program staff and purchased from Channing
Bete Corporation, South Deerfield, Mass) were sent to
members. PSRs made follow-up phone calls within two
weeks of patient receipt of such materials. During phone
contact, patients might be referred to a range of care
providers, including primary care physicians or mental
health providers, or connected to community services,
such as Meals On Wheels, transportation services, or
adult day care.
Study design
This model was tested as a randomized controlled
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prospective open trial. The study protocol was reviewed
and approved by the Thomas Beam Institutional Review
Board, New York, NY, and the surveys and promotional
materials were reviewed and approved by the Center for
Medicare and Medicaid Services. Study participants were
derived from approximately 13,000 members of an
Medicare Plus Choice HMO who resided in nine contigu-
ous counties surrounding Pittsburgh, Pa. To be eligible,
participants had to be
aged 65 or older, have
signed consent on their
health plan enrollment
form to participate, and
have been continuously
enrolled with the health
plan for all of 1999.
Members who declined to
participate in the study
or who opted out during
the study continued to
receive their usual bene-
fits. 
A subset of members
receiving medical care
under a special financial
risk arrangement with
certain providers was
excluded from the study.
This was done because of
the potentially different
nature of utilization in a
full-risk provider rela-
tionship. All other eligi-
ble health plan members
in the targeted counties
were randomized and
included in the study. To
minimize the chances
that spouses or neighbors would be split between study
and control groups, members were grouped by zip code and
these zip codes were randomized with a random number
generator within SAS statistical software (SAS Institute
Inc, Cary, NC). Neither subjects nor clinicians could be
blinded to the intervention. Aside from two physician
group practices, no providers had more than 5% of their
practice composed of study subjects. This low penetration
may have made it less likely that physician behavior
would be influenced much by whether or not a patient was
part of this study. Of the 8504 eligible members who par-
ticipated, 4247 were randomly assigned to the control and
4257 to the intervention group. A summary of enrollment
and attrition versus retention throughout the study is
shown in the Figure.
Measurements and outcomes
The primary outcomes
analyzed included self-
reported health status,
member satisfaction,
costs measured as paid
claims, and use of hospi-
tal and nursing home
resources measured as
bed-days per thousand
per year. Secondary out-
comes included survival
and disenrollment from
the health plan.
Analyses were based
on the intention to treat
principle (i.e., for those
who disenrolled from the
health plan data were
analyzed up to the point
of disenrollment). For
151 members who
declined to continue to
participate in SLM but
remained in the plan, all
18 months of data were
analyzed as part of the
intervention group.
Health status was meas-
ured by administering
the SF-36 at entry, at 12
months, and at 18 months. Surveys were conducted by a
vendor (Geriatric Health Services, San Francisco, Calif)
using personnel blinded to the study objectives. All active
and enrolled intervention and control members were sur-
veyed at each of the three points. Response rates were
nearly identical in both groups. At baseline, 73.7% of inter-
vention and 71.1% of control subjects responded. For the
final survey, response rates for active participants were
78% for the intervention group and 75% for the control
group. Data collected by mail and by telephone survey
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Figure. Flow chart illustrating participant eligibility, exclusion, enrollment, retention,
survey participation, and attrition, including a comparison of the intervention and
control groups, throughout the randomized controlled open trial.were analyzed together. Comparisons of baseline and 18-
month data were used for the primary analysis. Patient
satisfaction was assessed based on the Medicare
Beneficiary Survey. 
The cost of the intervention included the salaries and
overhead of all personnel delivering care services (includ-
ing the medical director and administrative staff) plus all
mailings, educational materials, and vendor costs specific
to the program. This amounted to an additional $10.50 per
member per month. 
Statistical analyses
For baseline comparisons, bivariate analyses described
the characteristics of study participants using t-tests to
compare the intervention and control groups. All variables
were subjected to two-tailed tests of significance with sta-
tistical significance set at P = .05. Disenrollments from the
study (voluntary disenrollments and death) were analyzed
with Kaplan-Meier and log-rank tests.
Health care resource use and costs were analyzed for the
baseline period (January 1999 through December 1999)
and for the study period (January 2000 though June 2001).
Cost outcomes were actual paid amounts on claims for
services incurred in the baseline and study periods. Cost
data from outsourced mental health services could not be
obtained for use in this analysis. All primary care services
were capitated in both the intervention and control groups,
were therefore essentially identical, and were thus also not
included in the final analysis. Based on plan estimates,
claims data were 98% complete. Claims were identified
using a unique program code assigned at the outset of the
study by information services personnel not involved in
the analysis. Costs per member in both baseline and study
periods for the intervention and control groups were not
normally distributed due to small numbers of individuals
with very high aggregate costs. Despite the non-normal
distribution, means were reported and t-tests were used to
assess differences in cost outcomes, as has been recom-
mended for the economic evaluation of health care 
randomized trials (17,18). Additional analyses using log
transformation yielded identical conclusions.
Resource use is reported for inpatient and skilled nurs-
ing/rehabilitation facility categories and was measured
using actual days incurred on paid claims. To assess dif-
ferences in rates of use, chi-squared tests were performed
using the number of individuals who did or did not have an
admission in each group. Admissions and bed-days were
also reported per 1000 members per year, thus automati-
cally adjusting for attrition by the change in denominator.
To assess change in self-reported health outcomes,
health assessment baseline scores were subtracted from
final scores for individuals who responded to both surveys,
and a matched-pair t-test was used to compare the first
and final surveys and report results for each of the 
SF-36 domains. 
Role of funding sources
Employees of Coventry Health Care, Inc (Bethesda, Md)
and Merck & Company, Inc (West Point, Pa) participated
in the study as coinvestigators. They implemented proto-
cols, coordinated data collection, and performed statistical
analyses. Data interpretation and decisions about the
paper’s content resided with the investigators.
Results
At baseline, there were no significant differences
between the two groups in demographic and health sta-
tus characteristics (Table 1). Data on race and socioeco-
nomic status were not available. Health care costs 
were higher in the intervention group for the one-year
preenrollment period (mean $3553 vs $3417), but this
was not significant. During the 18 months of this study,
SLM participants received substantially augmented
services in comparison to the control group. The follow-
ing data illustrate the scope of the intervention. PSRs
administered more than 24,186 health status short
assessments by telephone. A total of 1640 (38.5%) inter-
vention group members were evaluated for case man-
agement. Two hundred seventy-three home safety
assessments were performed, 419 clinical summaries
were mailed to treating physicians, and more than 800
alerts were faxed to physicians regarding potential med-
ication safety issues. No similar activities were per-
formed for the control group.
Over the 18 months of the study, self-reported satisfac-
tion with the health plan improved significantly in the
intervention group (P < .01) and self-reported social func-
tion declined less (P = .04) as measured by the SF-36
(Table 2). There was a trend toward slower decline in
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general health in the intervention group, which did not
reach significance (P = .09). There was no meaningful dif-
ference in subject attrition between the two groups. 
There was a 10% difference in mortality rate favoring
the intervention group, but the difference was not statisti-
cally significant by Kaplan-Meier analysis. In the inter-
vention group, there were 191 deaths out of 4257 (4.5%)
and in the control group, there were 211 deaths out of 4247
(5.0%) (P = .18). The study was never powered to detect a
difference in survival in post hoc analysis; however, the
power to detect a mortality difference at a = .05 was 17.8%.
Disenrollment rates from the health plan were also exam-
ined with Kaplan-Meier methodology, and again there was
no difference between intervention and control.
Costs were greater during the 18-month study period
than during the prior 12 months in both SLM and control
groups, reflecting double-digit medical-cost inflation.
There were no significant differences in mean costs during
either the baseline or intervention periods. Pharmacy
costs were nearly identical during the intervention period
($57.20 per member per month in control and $56.39 per
member per month in intervention groups). The cost of the
intervention was $10.50 per member per month or $189
per member per month over the 18-month period of the
study. Hospital inpatient utilization was not different
between the intervention and control groups during the
study (Table 3). Use of nursing homes, however, was lower
in the intervention group during the study period (616 vs
747 days per thousand members per year, P = .02).
Economic savings in the intervention group offset the costs
of the program so that total costs (including the cost of the
intervention) in the two groups were nearly identical
(Table 3). As a check against retention bias, the costs of
members lost through death or disenrollment were exam-
ined and found to be the same in both the intervention and
control groups. 
Discussion
Because a small proportion of Medicare beneficiaries
account for a large fraction of expenditures (approximate-
ly 10% of the noninstitutionalized patients accounting for
70% of expenditures) (20), and because a person with a
chronic disease may be expected to incur costs that are
80% to 300% higher than average (21), substantial savings
might be realized by managing the high cost of the “sick-
est of the sick.” This is the rationale for traditional disease
management and case management strategies and has
been recently reiterated as a method of reducing Medicare
spending (22). 
Historical attempts to target and intervene in the sub-
set of patients who might use a high volume of health
service resources have yielded mixed results. A program
designed to increase access to primary care after hospital
discharge increased rather than decreased rates of re-
hospitalization (23), and a case management program
using nurse case managers increased emergency depart-
ment visits without favorably influencing any other
measures (24). A review of three Medicare case manage-
ment demonstration projects revealed that none
improved self care, reduced symptoms, reduced hospital
admission rates, or reduced Medicare spending (7). These
failures were attributed to poor cooperation from clients’
physicians, lack of focus on interventions, and lack of
financial incentive to reduce expenditures. Another
review of 16 demonstration projects concluded that the
projects generally failed to meet their goal of overall cost
savings (25). A third review of 36 studies led the authors
to conclude that there was little or no effect on survival,
functional health, or use of hospitals or nursing homes
(26). While one of the earlier studies of a geriatric evalu-
ation and treatment program yielded both cost savings
and lower mortality (27), this encouraging result was not
confirmed in larger, multisite trials (28,29). In a study
similar to the one we report, social-work–directed case
management in a Medicare Plus Choice plan did not
reduce cost of health care of high-risk members (30).
Other reports have suggested that targeted interven-
tions may be worthwhile. For example, early comprehen-
sive discharge planning and home follow-up with an
advance practice nurse lowered readmission rates rates
and resulted in increased time between admissions with
attendant cost savings (31). A case-management study
reported significant reduction in costs, fewer readmis-
sions, and higher quality of life through careful targeting
of patients with congestive heart failure (32), and a nurse
case-management program for chronic heart failure
implemented by telephone lowered inpatient costs by
45.5% at six months (33). An intriguing study of substi-
tuting telephone care for clinic visits not only reduced
clinic visits as expected but also resulted in fewer hospi-
tal admissions, lower medication use, and an estimated
28% lower total expenditure per patient (34). 
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have been found to be efficacious in experimental 
settings would be scalable to broader implementation.
Demonstrating population-level changes with the inter-
ventions described is challenging, because large changes
in a small number of individuals are diluted, and differ-
ences are often obscured by year-to-year variation. The
short 18-month intervention period for this study com-
pounded the challenge of demonstrating improved health
outcomes and cost savings. Some savings were achieved by
shifting from higher-cost, institution-based, long-term care
to lower-cost, community-based care, which confirms the
findings of others (25). From a global perspective, howev-
er, these savings barely offset the cost of the intervention.
Because start-up costs would be expected to be higher than
maintenance costs, and because economies of scale might
be realized in program expansion, adding more members
to the program might enhance its efficiency.
Although there was no difference in mortality, other
benefits, such as improved social well-being and greater
satisfaction with care, were demonstrated. Even though
these benefits did not translate into improved member
retention, preservation of social relations is a health goal
highly valued by elderly patients (35). During the time of
this study, three competing Medicare Plus Choice health
plans served the nine-county region. Because voluntary
disenrollment rates from Medicare Plus Choice plans can
range from 10% to 15% per year, improved member reten-
tion was a hoped-for effect that did not materialize.
This study had several limitations. Measures of health
status and satisfaction relied on self-reporting, and the
study was conducted as an open trial. Another possible
weakness was that primary care physicians caring for
patients in this study were reimbursed under a capitation
model. Thus, there was a financial disincentive for
providers to see patients more frequently in the office to
address concerns raised by case managers. Under a fee-
for-service model, physicians might have been more moti-
vated to see patients early and more frequently to address
concerns disclosed by case mangers. While this might
have helped avoid costly hospital admissions, the more
frequent visits would themselves drive up costs, thereby
making the cost-offset analysis less favorable. It is impos-
sible to know which of these trends would dominate, and
one cannot conclude that the model would perform better
under a fee-for-service model. 
Although historical plan data were used to flag members
for evaluation for case management, the final selection for
case management was based more on clinical judgment
than on a highly refined methodology such as risk model-
ing. This targeting issue, and difficulties encountered 
in coordinating services in the provider community and
preprogram sources of care, represented weaknesses in
the intervention.
Strengths of the SLM design were comprehensiveness,
proactive case finding, and attempts to deal with the myr-
iad challenges affecting the health status of the elderly.
Since the study was broadly implemented to include all
members of a community eligible for Medicare Plus
Choice, and because the demographic and health assess-
ment characteristics were similar to those observed else-
where (nearly identical to the published norms in the case
of Mental and Physical Summary Scores for the SF-36)
(36), the findings may be generalizable to other Medicare
Plus Choice plans. However, this study reflected one geo-
graphic area and only members of one Medicare Plus
Choice plan. 
While from a scientific perspective it would have been
desirable to extend the study time, this duration repre-
sented a real-world compromise that acknowledged both
business and scientific objectives. It is unknown whether
the effectiveness of SLM might have been greater over a
longer time frame.
Lessons learned from this project point the way 
to potentially more rewarding implementations.
Interventions could have been better targeted, perhaps
through risk modeling. More cooperation from the
provider community would have greatly enhanced
attempts at early intervention. Future studies should
explore better ways to share information and ways to
reward provider efficiency and high-quality care.
Finally, the algorithms used in the electronic manage-
ment record to identify actionable issues and prompt the
case manager could be improved with higher levels of
medical logic and sophistication. 
In summary, this broad implementation of population-
based disease management and case management does
not represent a panacea for escalating medical costs and
raises a cautionary note.
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Tables
Table 1.  Baseline Demographic and Health Status Characteristics, Survey Participants in Medicare Plus Choice Health
Maintenance Organization (n = 6158), Pittsburgh, Pa, 1999a
Intervention Control
Group Group
Characteristics (n = 3137)   (n = 3021)  P
Age, mean (SD), years
Male, %
1999 Medical claim expenditure, mean (SE), $
How would you rate all your experiences with the plan now? 
(0 = worst to 10 = best)
General health
Bodily pain
Mental health
Physical function
Role limitation — emotional
Role limitation — physical
Social function
Vitality
Mental component — summary score
Physical component — summary score
72.9 (5.78)
47.0
3553 (150)
8.92
64.92
67.60
78.11
71.23
81.15
66.73
84.37
59.73
53.04
43.66
72.9 (5.82)
47.2
3417 (149)
8.79
65.13
67.00
78.02
70.59
80.98
66.53
84.44
60.05
53.13
43.48
.82
.88
.41
.16
.70
.30
.84
.36
.85
.85
.91
.57
.68
.54
Demographics
aAll data are weighted.
bThe SF-36 generates a health profile consisting of eight scales and two summary measures relating to 1) behavioral functioning, 2) perceived well-being,
3) social and role disability, and 4) personal evaluation of general health. Raw scores are translated into a scale of 0 to 100, with higher scores indicating
better functioning (19). 
Historical health care resource use
Satisfaction
SF-36 domainsb
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Table 2.  Change in Health Status and Satisfaction from Baseline to 18 Months, Study Participants, Medicare Plus Choice
Health Maintenance Organization, Pittsburgh, Pa, 2000–2001
Intervention Control
Group Group P
General health
Bodily pain
Mental health
Physical function
Role limitation — emotional
Role limitation — physical
Social function
Vitality
Mental component — summary score
Physical component — summary score
Satisfaction
How would you rate all your experiences with the plan now? 
(0 = worst to 10 = best)
-1.50
-0.78
-0.13
-4.29
-2.73
-3.09
-1.42
-1.53
-0.16
-1.25
0.32
-2.29
-1.42
0.01
-4.04
-2.24
-4.45
-2.77
-2.28
-0.23
-1.56
0.12
.09
.35
.74
.67
.66
.28
.04
.14
.79
.21
<.01
SF-36 domainsa
Satisfaction
aThe SF-36 generates a health profile consisting of eight scales and two summary measures relating to 1) behavioral functioning, 2) perceived well-being,
3) social and role disability, and 4) personal evaluation of general health. Raw scores are translated into a scale of 0 to 100, with higher scores indicating
better functioning (19). 
Table 3.  Financial and Resource Utilization Summary, Study Participants, Medicare Plus Choice Health Maintenance
Organization, Pittsburgh, Pa, 2000–2001
Study Period (18 months)
Measure Intervention Control P
Mean medical cost per member $ (SE)
Intervention cost per member $
Total mean cost per member $
Inpatient admissions per 1000 per year
Inpatient days per 1000 per year
Skilled nursing facility admissions per 1000 per year
Skilled nursing facility days per 1000 per year
6828 (230)
189
7017
430
1929
36
616.3
7001 (249)
0
7001
421
1989
37
747.7
.61
NAa
NA
.89
.46
.73
.02
aNA indicates not applicable.
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